A review of binimetinib for the treatment of mutant cutaneous melanoma.

about

Development of encorafenib for BRAF-mutated advanced melanoma.

P2860

Q47550452-28132BF0-DF60-4D52-847A-9E5D57E3AA90

P2860

A review of binimetinib for the treatment of mutant cutaneous melanoma.

Item

http://www.wikidata.org/entity/Q38674107

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

A review of binimetinib for the treatment of mutant cutaneous melanoma.

@en

type

Item

label

A review of binimetinib for the treatment of mutant cutaneous melanoma.

@en

prefLabel

A review of binimetinib for the treatment of mutant cutaneous melanoma.

@en

P1476

A review of binimetinib for the treatment of mutant cutaneous melanoma.

@en

P2093

Joelle Dornbierer

http://www.w3.org/2001/XMLSchema#string

Peter Koelblinger

http://www.w3.org/2001/XMLSchema#string

Reinhard Dummer

http://www.w3.org/2001/XMLSchema#string

P2860

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations

Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy

Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis.

Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial.

MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study.

Combined vemurafenib and cobimetinib in BRAF-mutated melanoma.

Improved overall survival in melanoma with combined dabrafenib and trametinib.

Mutations of the BRAF gene in human cancer

BRAF mutation predicts sensitivity to MEK inhibition

P304

1755-1766

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FON-2017-0170

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28587477

http://www.w3.org/2001/XMLSchema#string

A review of binimetinib for the treatment of mutant cutaneous melanoma.

about

P2860

P2860

A review of binimetinib for the treatment of mutant cutaneous melanoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698